X-ray repair cross-complementing group 1 (XRCC1) is one of the key components in the base excision repair pathway that repairs erroneous DNA lesions and removes nonbulky base adducts for the maintenance of genome integrity. Studies have revealed that differences in individual DNA repair capacity can impact the interindividual variation in cancer susceptibility, tumour aggressiveness and treatment response. The relationship between XRCC1 and sporadic colorectal cancer (CRC) susceptibility, which is hitherto inconclusive, has been explored in many association studies of different populations. In view of the conflicting findings generated, we aimed to investigate the association between XRCC1 and genetic predisposition to CRC among Malaysians. The present case-control association study was conducted on 130 CRC patients and 212 age-matched healthy controls. The genotyping of XRCC1 Arg194Trp, Arg280His and Arg399Gln single nucleotide polymorphisms was performed with allele-specific real-time PCR approach. This was followed by basic statistical analysis on the single nucleotide polymorphisms and haplotype data obtained. No significant difference in the allele and genotype frequencies was observed between CRC patients and healthy controls (P > 0.05). There was also no association observed between XRCC1 haplotypes and CRC (P > 0.05). In conclusion, a positive association between XRCC1 gene polymorphisms and CRC risk was not established in our Malaysian population.
Introduction
Our body is constantly exposed to endogenous normal cellular metabolism byproducts and environmental hazards that can induce damage to our genomic DNA. DNA repair machinery thus acts as a pivotal caretaker in safeguarding and maintaining the genome integrity for physiological function of cells and tissues (Friedberg, 2008; Huang et al., 2015) . There is evidence that any anomaly of components of the DNA repair mechanism will modulate an individual's DNA repair capacity and lead to deleterious consequences (e.g. carcinogenesis) (Hoeijmakers, 2001; Friedberg, 2003; Kaina, 2003; Tomlinson et al., 2012) . The base excision repair (BER) pathway is directed towards the repair of small DNA lesions and nonbulky adducts, whereas single-strand breaks are targeted by the singlestrand break repair (SSBR) pathway Wilson and Bohr, 2007) . Interindividual polymorphic variations in DNA repair genes have been reported to be responsible for the interindividual differences in cancer risk, prognosis, and response to cancer therapy, by conferring interindividual variation in DNA repair capacity (Berwick and Vineis, 2005 ; Gossage et al., 2012).
X-ray repair cross-complementing group 1 (XRCC1) protein, a scaffolding protein encoded by the XRCC1 gene at chromosome 19q13.2, has been widely studied because of its key mechanistic roles in both the BER and SSBR pathways (Vidal et al., 2001; Wood et al., 2001; Gao et al., 2014) . XRCC1 deficiency has been shown to evoke mutagenesis, making the embryonic knock-out of this protein lethal (Thompson and West, 2000) . The XRCC1 protein either functions in a complex by interacting with other BER components -that is, DNA ligase III, DNA polymerase β, poly(ADP-ribose) polymerase, polynucleotide kinase and apurinic/apyrimidinic endonuclease I -or acts independently by directly binding to the gapped and nicked DNA (Caldecott et al., 1996; Marintchev et al., 1999; Fortini and Dogliotti, 2007) . The XRCC1 gene is composed of 17 exons with more than 300 polymorphisms reported thus far. Of all, three single nucleotide polymorphisms (SNPs) in the conserved region of the XRCC1 gene are the most extensively studied -that is, Arg194Trp (C > T), Arg280His (G > A) and Arg399Gln (G > A). These coding polymorphisms in exons 6, 9 and 10, respectively, result in amino acid substitutions and altered protein function, which can modulate the DNA repair capacity and influence the individual's susceptibility to cancer (Shen et al., 1998; Ladiges, 2006; Zhao et al., 2012; Li et al., 2014) .
Sporadic colorectal cancer (CRC) is often attributed to a set of low-penetrance genes, including DNA repair genes that confer a modest genotypic risk in modulating the individual's susceptibility to CRC (Heavey et al., 2004; Houlston and Peto, 2004; Kotnis et al., 2005; Stern et al., 2007; Vodicka et al., 2007; Jiang et al., 2010; Tomlinson et al., 2012) . Numerous genetic association studies and meta-analyses have been performed to investigate the relationship between XRCC1 gene polymorphisms and susceptibility to CRC in different populations, but the findings obtained to date are conflicting and inconclusive (Engin et al., 2011; Gsur et al., 2011; Muniz-Mendoza et al., 2012; Yin et al., 2012; Zhang et al., 2012; Zhao et al., 2012; Liu et al., 2013; Lu et al., 2013; Nissar et al., 2013 Nissar et al., , 2015 Tian et al., 2013; Zeng et al., 2013; Huang et al., 2015) . There is also a lack of information on XRCC1 related to CRC susceptibility in Malaysians. With this in mind, a hospital-based case-control study was performed with the aim to assess the association between XRCC1 Arg194Trp, Arg280His and Arg399Gln, and CRC risk among Malaysians.
Patients and methods

Study participants
A cohort of 130 CRC patients admitted in the University Malaya Medical Centre in Kuala Lumpur, and Queen Elizabeth Hospital in Sabah, Malaysia, between 2008 and 2013 volunteered for this study. All recruited cases were newly diagnosed in whom there was no history of hereditary CRC syndrome, cancer of any sort or family history of CRC. The age of the patients ranged from 40 to 90 years and the patients manifested different stages of CRC, ranging from stages I to IV. A total of 212 agematched healthy controls who were CRC-free at the time of sampling were also randomly recruited. Peripheral blood samples were collected from the patients and controls after obtaining written informed consent and with the approval from the Medical Ethics Committee of University Malaya Medical Centre (Ref. no.: 654.1).
Genotyping of XRCC1 Arg194Trp, Arg280His and Arg399Gln
Genomic DNA was isolated from the blood of patients and controls using an in-house phenol-chloroform DNA extraction method (Lau et al., 2014; Chua et al., 2015) . The concentration and purity of the extracted DNA were determined before subsequent XRCC1 genotyping using the Applied Biosystems Predesigned TaqMan SNP Genotyping Assays (Thermo Fisher Scientific, Waltham, Massachusetts USA) ( Table 1) .
Real-time PCR was performed in singleplex reactions containing 5 μl of 2 × TaqMan GTXpress master mix, 0.5 μl of 20 × TaqMan SNP Genotyping Assay, 20 ng of DNA template and deionized water, in a total volume of 10 μl. The thermal cycling conditions for fast genotyping on Applied Biosystems 7500 Fast Real-Time PCR System (Applied Biosystems, Waltham, Massachusetts, USA) were as follows: DNA polymerase activation at 95°C for 20 s; 40 cycles of denaturation at 95°C for 3 s and annealing/extension at 60°C for 30 s.
Statistical analysis
The observed genotype frequencies in the control group were verified for concordance to Hardy-Weinberg equilibrium by calculating the expected frequencies and significance testing using Pearson's χ 2 -test. The significance of differences in observed genotype and allele frequencies between CRC patients and healthy controls was assessed using Fisher's exact test, where a P value of less than 0.05 is considered statistically significant. Odds ratio (OR) with 95% confidence interval (CI) was also determined. On the basis of the genotype data of these XRCC1 gene variants, the computation of linkage disequilibrium (LD) and characterization of haplotype patterns were performed using the Haploview software, version 4.2. The pairwise measurement of LD was performed and haplotype block was defined using the default 'Confidence Intervals' algorithm proposed by Gabriel et al. (2002) . The haplotype phasing and population frequency estimation were based on the accelerated expectation maximization algorithm (Barrett et al., 2005) .
Results
The observed genotype frequencies of XRCC1 Arg194Trp, Arg280His and Arg399Gln in the control group were within the probability limits for HardyWeinberg equilibrium (P > 0.05). As shown in Table 2 , the homozygotes of minor alleles of these XRCC1 SNPs were in very low frequencies (i.e. less than 10.0%) among both CRC patients and healthy controls. The A/A genotype of Arg280His was particularly rare and identified in only one healthy control (0.5%), and was not detected among the CRC patients (Table 2 ). Statistical analysis with Fisher's exact test failed to establish any significant association between the common XRCC1 variants and CRC susceptibility in our Malaysian population (P > 0.05) ( Table 2) .
On the basis of haplotype analysis, XRCC1 Arg194Trp, Arg280His and Arg399Gln polymorphisms were in strong 
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LD. The predicted allele combinations of these three XRCC1 SNPs were 194Arg-280Arg-399Arg, 194Arg-280Arg-399Gln, 194Trp-280Arg-399Arg and 194Arg-280His-399Arg. However, the observed differences in haplotype frequencies between cases and controls were not statistically significant (P > 0.05) through the association test (Table 3) .
Discussion
Much effort has been focused on addressing the relationship between XRCC1 coding polymorphisms and susceptibility to CRC in the past decades. Arg194Trp and Arg399Gln have been the most extensively studied among the three biologically plausible XRCC1 variants for their potential roles as modifiers of CRC risk. Although Abdel-Rahman et al. (2000) initiated studies on the association between XRCC1 Arg194Trp, Arg399Gln and CRC risk more than a decade ago, the relationship between XRCC1 and CRC still remains elusive with discrepancies reported in studies (Engin et al., 2011; Gsur et al., 2011; Muniz-Mendoza et al., 2012; Yin et al., 2012; Zhao et al., 2012; Lu et al., 2013; Nissar et al., 2013 Nissar et al., , 2015 Tian et al., 2013; Huang et al., 2015) . In the present study, the XRCC1 Arg194Trp, Arg399Gln and Arg280His appear not to be associated with the risk of developing CRC in the Malaysian population studied.
Previous meta-analyses and case-control studies conducted in Austria, Mexico, Japan and China also reported similar findings for XRCC1 Arg194Trp (Jiang et al., 2010; Wang et al., 2010; Gsur et al., 2011; Muniz-Mendoza et al., 2012; Yin et al., 2012; Liu et al., 2013; Gao et al., 2014; Huang et al., 2015) . Nevertheless, Nissar et al. (2015) showed an association of XRCC1 Arg194Trp with risk for CRC among Kashmiris. Overall, the genotype frequency of XRCC1 Arg194Trp in our Malaysian population is similar to those noted in other Asian populations, where the T/T genotype was the least frequently encountered (Yin et al., 2012; Gao et al., 2014; Huang et al., 2015) . Interestingly, the minor allele T homozygotes are present at even lower frequencies or completely absent in Czechs, Egyptians, Norwegians, Mexicans, Austrians and Southern Italians, as opposed to our 7% (Abdel-Rahman et al., 2000; Skjelbred et al., 2006; Improta et al., 2008; Pardini et al., 2008; Gsur et al., 2011; Muniz-Mendoza et al., 2012) .
The Arg399Gln coding polymorphism is located at the C-terminal of the poly(ADP-ribose) polymerase interacting domain of XRCC1, and implicated in the protein-protein interaction in DNA repair mechanisms (Masson et al., 1998) . It was shown that the 399Gln allele is associated with reduced DNA repair capacity, as well as significantly increased the levels of DNA adduct and sister chromatid exchange frequency (Lunn et al., 1999; Duell et al., 2000) . The association between Gln/Gln genotype and perceptible increased CRC risk has been demonstrated in several meta-analyses and case-control studies (Abdel-Rahman et al., 2000; Jelonek et al., 2010; Yin et al., 2012; Zhao et al., 2012; Tian et al., 2013;  Wu et al., 2013; Poomphakwaen et al., 2014; Forat-Yazdi et al., 2015; Huang et al., 2015) . The present study, however, does not demonstrate a positive association between XRCC1 Arg399Gln and the risk of developing CRC among Malaysians. Our finding is further supported by epidemiological case-control studies conducted in Austria, Mexico, Norway, Southern Italy, Kashmir, Czech Republic, Turkey, Taiwan and China (Yeh et al., 2005; Skjelbred et al., 2006; Improta et al., 2008; Pardini et al., 2008; Engin et al., 2011; Gsur et al., 2011; Muniz-Mendoza et al., 2012; Nissar et al., 2013; Gao et al., 2014) .
To date, little work has been carried out on the link between XRCC1 codon 280 polymorphism and CRC. The 280His variant allele has been shown to have a reduced efficiency in cellular BER and SSBR pathways, which may then hasten genomic instability and trigger carcinogenesis (Takanami et al., 2005) . However, recent meta-analyses indicated that the Arg280His variant was not correlated with genetic predisposition to CRC (Wang et al., 2010; Zhang et al., 2012; Liu et al., 2013) . Our study also shows a lack of association in conferring CRC susceptibility among Malaysians, much similar to previous findings reported in China, Japan, South Korea and Norway (Hong et al., 2005; Skjelbred et al., 2006; Yin et al., 2012; Huang et al., 2015) .
In view of the increasing importance of common haplotype pattern and disease association, we also performed haplotype analysis on our dataset. Although the XRCC1 Arg194Trp, Arg280His and Arg399Gln polymorphisms were in strong LD, no significant association was established between the common combined alleles of XRCC1 SNPs and CRC risk. The common haplotypes of XRCC1 SNPs seen in our cohort are similarly described by Hong et al. (2005) , with 194Arg-280His-399Arg occurring least frequently in both theirs and our cohorts. In contrast to our findings, their group identified 194Arg-280Arg-399Gln to be associated with an increased CRC risk among the South Koreans.
To date, the investigations on the association between XRCC1 polymorphisms and CRC susceptibility, either through meta-analyses or independent case-control studies, have yielded conflicting results. This will have to be further unravelled by studies across varying ethnic and geographic backgrounds, keeping in sight other possible confounders (e.g. gene-environmental factors) that cannot be completely excluded in the roles of lowpenetrance genes on cancer susceptibility.
In conclusion, no positive association was observed between XRCC1 polymorphisms and CRC susceptibility, based on either independent SNPs or combined alleles, in our Malaysian cohort. Although the present study involves a relatively small sample, our findings are consistent with several other studies and meta-analyses. The lack of information on environmental factors (e.g.
smoking and alcohol consumption) is also one of the limitations of current study in addressing the association between XRCC1 polymoprhisms and CRC susceptibility. Hence, larger studies are definitely warranted to affirmatively determine the relationship between XRCC1 gene variants and haplotypes, environmental factors, and predisposition to CRC.
